サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751217

CROにおける医薬品分析試験サービス市場規模、シェア、動向分析レポート：サービス別、エンドユース別、地域別、セグメント予測、2025年～2030年

Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development & Validation), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
CROにおける医薬品分析試験サービス市場規模、シェア、動向分析レポート：サービス別、エンドユース別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月12日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場規模と動向：

CROにおける医薬品分析試験サービスの世界市場規模は、2024年に75億2,000万米ドルと推計され、2025年から2030年にかけてCAGR 8.61％で成長すると予測されています。

この成長の主な要因は、慢性疾患の蔓延、分析試験サービスのアウトソーシング需要、医薬品研究開発への投資、世界のコスト効率に優れた医薬品開発プロセスへのシフトなどです。

また、医薬品は、専門知識を活用し、インフラへの設備投資を最小限に抑え、医薬品承認プロセスや規制要件のタイムラインを合理化するために、CROへのアウトソーシングが増加しています。これらの検査は、原料分析や分析法のバリデーションから安定性試験や不純物プロファイリングに至るまで、開発全体を通じて不可欠です。

CROは質量分析、NGS、ラマン分光法、迅速かつ正確な検査のための自動化/AIなどの高度な分析技術を提供しているため、個別化医療や精密医療を開発するためのCROにおける医薬品分析検査サービスの需要が高まると予想されます。

さらに、生物製剤、バイオシミラー、先端療法のパイプラインの増加、医薬品の安全性、有効性、一貫性を高めるための厳格な品質管理の高まりなどの要因が、市場の成長に寄与しています。また、CROにおける自動化、人工知能、ラボ情報管理システム（LIMS）のようなデジタルデータ管理システムの採用拡大が、分析試験プロセスの効率と信頼性を高めると予想されています。このため製薬企業は、イノベーションを促進し、リスクを低減し、市場投入までの時間を改善するコスト削減戦略や戦略的提携のために、CROとの提携を拡大することになりました。

さらに、世界的に規制の枠組みが厳しいことも、CROにおける医薬品分析試験サービス市場の主要な促進要因となっています。米国FDA、EMA、PMDA、WHOなどの規制当局は、医薬品の安全性、有効性、品質を高めるため、包括的な分析バリデーション、分析法開発、安定性試験を要求しています。これらの規制はますます厳しくなっており、特に複雑な生物製剤、バイオシミラー、先進治療薬では、詳細な特性解析と不純物プロファイリングが義務付けられています。ICHガイドライン（Q2、Q3、Q6）およびGMP/GLP基準の施行は、準拠した分析手法への要求を強めています。頻繁な監査や規制当局の査察は、製薬会社が世界な規制に関する知識、検証されたインフラ、品質管理システムを有する専門CROと契約することにさらに影響を与え、リスクの軽減、承認の迅速化、地域を超えた持続的な市場アクセスを可能にしています。

さらに、製品開発への体系的アプローチを重視するQuality by Design（QbD）原則の採用は、初期段階での分析特性評価の重要性を浮き彫りにしています。QbDの枠組みのもとで、製薬会社は重要品質特性（CQA）を定義し、原材料や製造工程のばらつきが製品の性能を損なわないようにしなければなりません。FDAのプロセス分析技術（PAT）イニシアチブは、製品の一貫性を維持するために、製造パラメータのリアルタイムモニタリングを推進しています。このような規制の後押しと、より洗練された製剤への移行が相まって、医薬品分析試験におけるCROの役割は拡大しつつあります。このような要因が、近い将来、市場全体の需要を押し上げると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 CROにおける医薬品分析試験サービス市場：変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 価格モデル分析
  • テクノロジー情勢
  • 市場分析ツール
    • ポーターのファイブフォース分析
    • SWOT分析によるPESTEL
    • COVID-19の影響分析

第4章 CROにおける医薬品分析試験サービス市場：サービス別　推定・動向分析

  • CROにおける医薬品分析試験サービス市場（サービス別）：セグメントダッシュボード
  • CROにおける医薬品分析試験サービス市場（サービス別）：変動分析
  • サービス別、2018年～2030年
  • 生体分析試験
    • 臨床
    • 非臨床
  • 方法開発と検証
    • 抽出可能および浸出可能
    • 不純物法
    • 技術コンサルティング
    • その他
  • 安定性試験
    • 薬物成分
    • 安定性指示法の検証
    • 加速安定性試験
    • 光安定性試験
    • その他
  • その他

第5章 CROにおける医薬品分析試験サービス市場：最終用途別　推定・動向分析

  • CROにおける医薬品分析試験サービス市場（最終用途別）：セグメントダッシュボード
  • CROにおける医薬品分析試験サービス市場（最終用途別）：変動分析
  • 最終用途別、2018年～2030年
  • 製薬会社
  • バイオ医薬品企業
  • その他

第6章 CROにおける医薬品分析試験サービス市場：地域別　推定・動向分析

  • 地域別市場ダッシュボード
  • 地域別市場シェア分析、2024年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • デンマーク
    • ノルウェー
    • ポーランド
    • スイス
    • オーストリア
    • チェコ共和国
    • クロアチア
    • スロベニア
    • ギリシャ
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • タイ
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 市場参入企業の分類
  • 企業市場シェア/評価分析、2024年
  • 企業プロファイル
    • SGS Societe Generale de Surveillance SA
    • Worldwide Clinical Trials
    • Sofpromed
    • ClinChoice
    • Evotec
    • Eurofins Scientific
    • KYMOS Group
    • ViviaBiotech SL
    • GalChimia
    • TCI Laboratories
    • Cotecna（NEOTRON SpA,）
    • Tentamus
    • Enzymlogic
    • Pharmbiotest
    • UNIFARM-Research Centre
    • ANAPHARM EUROPE, SLU
図表

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 5 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 9 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 11 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 13 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 15 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 18 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 20 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 22 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 23 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 24 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 26 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 28 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 30 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 32 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 34 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 36 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 38 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 40 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 42 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 44 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 46 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 48 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 53 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 54 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 55 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 56 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 57 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 59 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 61 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 63 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 65 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 66 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 68 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 70 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 74 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 75 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 78 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 79 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 81 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Pharmaceutical Analytical Testing Services in CRO Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Pharmaceutical Analytical Testing Services in CRO Market: Service outlook and key takeaways
  • Fig. 20 Pharmaceutical Analytical Testing Services in CRO Market: Service movement analysis
  • Fig. 21 Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others Service Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical Analytical Testing Services in CRO Market: End Use outlook and key takeaways
  • Fig. 37 Pharmaceutical Analytical Testing Services in CRO Market: End Use movement analysis
  • Fig. 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key Country Dynamics
  • Fig. 46 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key Country Dynamics
  • Fig. 51 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key Country Dynamics
  • Fig. 53 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key Country Dynamics
  • Fig. 55 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key Country Dynamics
  • Fig. 57 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key Country Dynamics
  • Fig. 59 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key Country Dynamics
  • Fig. 86 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key Country Dynamics
  • Fig. 88 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key Country Dynamics
  • Fig. 90 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key Country Dynamics
  • Fig. 92 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key Country Dynamics
  • Fig. 95 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key Country Dynamics
  • Fig. 97 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 MEA Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key Country Dynamics
  • Fig. 100 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key Country Dynamics
  • Fig. 102 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key Country Dynamics
  • Fig. 104 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key Country Dynamics
  • Fig. 106 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key company categorization
  • Fig. 108 Service heat map analysis
  • Fig. 109 Strategic framework
目次
Product Code: GVR-4-68040-576-3

Market Size & Trends:

The global pharmaceutical analytical testing services in CRO market size was estimated at USD 7.52 billion in 2024 and is projected to grow at a CAGR of 8.61% from 2025 to 2030. This growth is primarily attributed to factors such as the growing prevalence of chronic diseases, demand for outsourcing analytical testing services, investments in pharmaceutical R&D, and a shift toward cost-efficient drug development processes across the globe.

In addition, pharmaceuticals are increasingly outsourced to CROs to utilize specialized expertise, minimize their capital investment in the infrastructure, and streamline the timelines for the drug approval process and regulatory requirements. These tests are essential throughout development, from raw materials analysis and method validation to stability studies and impurity profiling.

As CROs offer advanced analytical technologies such as mass spectrometry, NGS, Raman spectroscopy, and automation/AI for rapid and accurate testing are expected to enhance the demand for pharmaceutical analytical testing services in CROs for developing personalized and precision medicine.

Moreover, factors such as an increasing pipeline of biologics, biosimilars, advanced therapies, and rising stringent quality control to enhance pharmaceutical products' safety, efficacy, and consistency are contributing to market growth. Besides, the expanding adoption of automation, artificial intelligence, and digital data management systems like Laboratory Information Management Systems (LIMS) in CROs is anticipated to boost the efficiency and reliability of analytical testing processes. This led pharmaceutical companies to expand their partnerships with CROs for cost-saving strategies and strategic collaborations that boost innovation, reduce risk, and improve time-to-market.

Furthermore, stringent regulatory frameworks worldwide are another major driver for the pharmaceutical analytical testing services in CRO market. Regulatory authorities such as the U.S. FDA, EMA, PMDA, and WHO require comprehensive analytical validation, method development, and stability testing to enhance drug safety, efficacy, and quality. These regulations are becoming increasingly stringent, particularly for complex biologics, biosimilars, and advanced therapies, mandating in-depth characterization and impurity profiling. The implementation of ICH guidelines (Q2, Q3, Q6) and GMP/GLP standards has intensified the demand for compliant analytical methodologies. Frequent audits and regulatory inspections further influence pharmaceutical companies to engage with specialized CROs possessing global regulatory knowledge, validated infrastructure, and quality management systems, allowing risk mitigation, faster approvals, and sustained market access across geographies.

Further, the adoption of Quality by Design (QbD) principles, which emphasize a systematic approach to product development, highlights the importance of early-stage analytical characterization. Under the QbD framework, pharmaceutical companies must define Critical Quality Attributes (CQAs) and ensure that variations in raw materials or manufacturing processes do not compromise product performance. The FDA's Process Analytical Technology (PAT) initiative promotes real-time monitoring of manufacturing parameters to maintain product consistency. This regulatory push, combined with the industry's transition toward more sophisticated drug formulations, is expanding the role of CROs in pharmaceutical analytical testing. Such aforementioned factors are expected to drive the overall market demand in the near future.

Global Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pharmaceutical analytical testing services in CRO market report based on service, end use and region.

  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Bioanalytical Testing
    • Clinical
    • Non-Clinical
  • Method Development & Validation
    • Extractable & Leachable
    • Impurity Method
    • Technical Consulting
    • Others
  • Stability Testing
    • Drug Substance
    • Stability Indicating Method Validation
    • Accelerated Stability Testing
    • Photostability Testing
    • Others
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
    • Poland
    • Switzerland
    • Austria
    • Czech Republic
    • Croatia
    • Slovenia
    • Greece
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Argentina
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Analytical Testing Services in CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Pricing Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Force Analysis
    • 3.5.2. PESTEL by SWOT Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Analytical Testing Services in CRO Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 4.4. Bioanalytical Testing
    • 4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Clinical
      • 4.4.2.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Non-Clinical
      • 4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Method Development & Validation
    • 4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Extractable & Leachable
      • 4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Impurity Method
      • 4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Technical Consulting
      • 4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Stability Testing
    • 4.6.1. Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Drug Substance
      • 4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Stability Indicating Method Validation
      • 4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Accelerated Stability Testing
      • 4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Photostability Testing
      • 4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Analytical Testing Services in CRO Market: End Use Estimates & Trend Analysis

  • 5.1. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Segment Dashboard
  • 5.2. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Movement Analysis
  • 5.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 5.4. Pharmaceutical Companies
    • 5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biopharmaceutical Companies
    • 5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Analytical Testing Services in CRO Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.10. Poland
      • 6.4.10.1. Key Country Dynamics
      • 6.4.10.2. Competitive Scenario
      • 6.4.10.3. Regulatory Framework
      • 6.4.10.4. Poland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.11. Switzerland
      • 6.4.11.1. Key Country Dynamics
      • 6.4.11.2. Competitive Scenario
      • 6.4.11.3. Regulatory Framework
      • 6.4.11.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.12. Austria
      • 6.4.12.1. Key Country Dynamics
      • 6.4.12.2. Competitive Scenario
      • 6.4.12.3. Regulatory Framework
      • 6.4.12.4. Austria Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.13. Czech Republic
      • 6.4.13.1. Key Country Dynamics
      • 6.4.13.2. Competitive Scenario
      • 6.4.13.3. Regulatory Framework
      • 6.4.13.4. Czech Republic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.14. Croatia
      • 6.4.14.1. Key Country Dynamics
      • 6.4.14.2. Competitive Scenario
      • 6.4.14.3. Regulatory Framework
      • 6.4.14.4. Croatia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.15. Slovenia
      • 6.4.15.1. Key Country Dynamics
      • 6.4.15.2. Competitive Scenario
      • 6.4.15.3. Regulatory Framework
      • 6.4.15.4. Slovenia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.16. Greece
      • 6.4.16.1. Key Country Dynamics
      • 6.4.16.2. Competitive Scenario
      • 6.4.16.3. Regulatory Framework
      • 6.4.16.4. Greece Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Australia
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. SGS Societe Generale de Surveillance SA
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Worldwide Clinical Trials
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Sofpromed
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. ClinChoice
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Evotec
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Eurofins Scientific
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. KYMOS Group
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. ViviaBiotech S.L.
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. GalChimia
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. TCI Laboratories
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Cotecna (NEOTRON SpA,)
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Service Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. Tentamus
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Service Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. Enzymlogic
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Service Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Pharmbiotest
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Service Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. UNIFARM - Research Centre
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Service Benchmarking
      • 7.3.15.4. Strategic Initiatives
    • 7.3.16. ANAPHARM EUROPE, S.L.U
      • 7.3.16.1. Company Overview
      • 7.3.16.2. Financial Performance
      • 7.3.16.3. Service Benchmarking
      • 7.3.16.4. Strategic Initiatives